UYG:ARCA-ProShares Ultra Financials (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 98.26

Change

+3.74 (+3.96)%

Market Cap

USD 0.75B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. FinancialsSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the financial services sector of the U.S. equity market. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Financial TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.97%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 9.27B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 8.27B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 8.18B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.76B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 4.34B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.09B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.89B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.77B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.77B

ETFs Containing UYG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.98% 76% C+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.98% 76% C+ 94% A
Trailing 12 Months  
Capital Gain 57.72% 88% B+ 95% A
Dividend Return 0.69% 26% F 9% A-
Total Return 58.41% 88% B+ 95% A
Trailing 5 Years  
Capital Gain 132.24% 80% B- 88% B+
Dividend Return 11.25% 92% A 32% F
Total Return 143.49% 80% B- 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 36.88% 64% D 90% A-
Dividend Return 38.79% 63% D 90% A-
Total Return 1.91% 89% A- 45% F
Risk Return Profile  
Volatility (Standard Deviation) 59.20% 70% C- 15% F
Risk Adjusted Return 65.52% 96% N/A 77% C+
Market Capitalization 0.75B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike